Intact regulation of muscle expression and circulating levels of myokines in response to exercise in patients with type 2 diabetes

Physiol Rep. 2018 Jun;6(12):e13723. doi: 10.14814/phy2.13723.

Abstract

Regular exercise plays an important role in the prevention and treatment of type 2 diabetes (T2D). The synthesis and secretion of myokines in response to contraction may contribute to the beneficial metabolic effects of exercise. However, some exercise-induced responses may be attenuated in T2D. Here, we investigated whether the effect of acute exercise on selected myokines are impaired in T2D. Skeletal muscle biopsies and blood samples were obtained from 13 men with T2D and 14 weight-matched, glucose-tolerant men before, immediately after and 3-h after acute exercise (60 min cycling) to examine muscle expression and plasma/serum levels of selected myokines. One-hour of exercise increased muscle expression of IL6, FGF21, ANGPTL4, CHI3L1, CTGF and CYR61, of which FGF21, ANGPTL4 and CHI3L1 increased further 3-h into recovery, whereas expression of IL6, CYR61, and CTGF returned to baseline levels. There was no immediate effect of exercise on IL15 expression, but it decreased 3-h into recovery. Plasma IL-6 increased robustly, whereas circulating levels of FGF21, ANGPTL4, IL-15, and CHI3L1 increased only modestly in response to exercise. All returned toward baseline levels 3-h into recovery except for plasma ANGPTL4, which increased further. No significant differences in these responses to exercise were observed between the groups. Our results demonstrate that muscle expression and circulating levels of selected known and putative myokines were equally regulated by acute exercise in patients with T2D and weight-matched controls. This suggests that the potential beneficial metabolic effects of these myokines are not impaired in patients with T2D.

Keywords: Exercise resistance; T2D; myokines; skeletal muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-Like Protein 4 / genetics
  • Angiopoietin-Like Protein 4 / metabolism
  • Case-Control Studies
  • Chitinase-3-Like Protein 1 / genetics
  • Chitinase-3-Like Protein 1 / metabolism
  • Connective Tissue Growth Factor / genetics
  • Connective Tissue Growth Factor / metabolism
  • Cysteine-Rich Protein 61 / genetics
  • Cysteine-Rich Protein 61 / metabolism
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Exercise / physiology*
  • Fibroblast Growth Factors / genetics
  • Fibroblast Growth Factors / metabolism
  • Gene Expression Regulation / physiology
  • Humans
  • Interleukin-15 / genetics
  • Interleukin-15 / metabolism
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Male
  • Middle Aged
  • Muscle Proteins / genetics
  • Muscle Proteins / metabolism*
  • Muscle, Skeletal / metabolism*

Substances

  • ANGPTL4 protein, human
  • Angiopoietin-Like Protein 4
  • CCN1 protein, human
  • CCN2 protein, human
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • Cysteine-Rich Protein 61
  • Cytokines
  • IL15 protein, human
  • IL6 protein, human
  • Interleukin-15
  • Interleukin-6
  • Muscle Proteins
  • fibroblast growth factor 21
  • Connective Tissue Growth Factor
  • Fibroblast Growth Factors